iifl-logo

Jenburkt Pharmaceuticals Ltd Share Price Live

Add as a Preferred Source on Google
₹1,003.9
(-2.23%)
Sep 11, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

No Chart Data Available

  • Open₹1,020
  • Day's High₹1,034.8
  • 52 Wk High₹1,073.9
  • Prev. Close₹1,026.8
  • Day's Low₹998.6
  • 52 Wk Low ₹998.6
  • Turnover (lac)17.89
  • P/E12.43
  • Face Value₹10
  • Book Value₹459.81
  • EPS80.96
  • Mkt. Cap (Cr.)₹443.05
  • Div. Yield2.05
View All Historical Data

No Record Found

No Record Found

Jenburkt Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹1,020

Prev. Close

₹1,026.8

Turnover(Lac.)

₹17.89

Day's High

₹1,034.8

Day's Low

₹998.6

52 Week's High

₹1,073.9

52 Week's Low

₹998.6

Book Value

₹459.81

Face Value

₹10

Mkt Cap (₹ Cr.)

443.05

P/E

12.43

EPS

80.96

Divi. Yield

2.05

Jenburkt Pharmaceuticals Ltd Corporate Action

5 May 2026

12:00 AM

AGM

Announcement Date: 05 May, 2026

arrow

29 Jul 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

5 May 2026

12:00 AM

Dividend

Dividend Amount: 20.7

Record Date: 28 Aug, 2026

arrow

Jenburkt Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Jenburkt Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

14 Sep, 2026|11:32 PM
Jun-2026Mar-2026Dec-2025Sep-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 46.61%

Foreign: 0.00%

Indian: 46.61%

Non-Promoter- 0.13%

Institutions: 0.12%

Non-Institutions: 53.25%

Custodian: 0.00%

Read More
Share PriceShare Price

Jenburkt Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2026Mar-2025Mar-2024Mar-2023

Equity Capital

4.41

4.41

4.41

4.41

Preference Capital

0

0

0

0

Reserves

192.63

167.36

140.53

117.98

Net Worth

197.04

171.77

144.94

122.39

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

123.98

109.29

118.89

114.67

yoy growth (%)

13.43

-8.07

3.67

11

Raw materials

-31.43

-30.09

-33.06

-33.99

As % of sales

25.35

27.53

27.81

29.64

Employee costs

-36.49

-32.37

-36.51

-27.69

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

29.87

21.64

21.13

25.26

Depreciation

-1.89

-2.03

-2.29

-1.5

Tax paid

-7.57

-5.13

-6.26

-8.05

Working capital

-4.98

-5.73

22.53

-2.1

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

13.43

-8.07

3.67

11

Op profit growth

37.36

0.49

-16.99

20.62

EBIT growth

37.03

2.08

-15.64

22.94

Net profit growth

35.11

10.98

-13.61

27.42

View Ratios

No Record Found

Jenburkt Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,840

138.814,41,957.51,115.140.875,641.3193.23

Divis Laboratories Ltd

DIVISLAB

9,322

82.642,47,5768910.322,974629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,965.5

92.271,89,233.014920.684,073222.76

Zydus Lifesciences Ltd

ZYDUSLIFE

1,119.1

30.641,11,670.55339.60.092,723.5237.3

Cipla Ltd

CIPLA

1,366

33.631,10,272.68862.160.954,672.12423.35

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Jenburkt Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director / M D / Promoter

Ashish U Bhuta

Executive Director / Whole Time Director / CFO

Dilip H Bhuta

Independent Non Exe. Director

Hina Ravindra Mehta

Independent Non Exe. Director

Sumit A. Thakkar

Independent Non Exe. Director

KRISHNAN SUBHARAMAN

Independent Non Exe. Director

PANKAJ ARUN DANTWALA

SVP / Company Secretary / Compliance Officer

ASHISH R SHAH

Registered Office

Nirmala Apartment P B No 37396,

93 Jayprakash Road Andheri(W),

Maharashtra - 400058

Tel: 91-22-66943121/67603603

Website: http://www.jenburkt.com

Email: investor@jenburkt.com

Registrar Office

Office No S6-2,

Pinnacle Busine.Park, Mahakali Caves Road,

Mumbai - 400093

Tel: 91-22-62638200

Website: www.bigshareonline.com

Email: investor@bigshareonline.com / info@bigshareonline.com

Summary

Jenburkt Pharmaceuticals Limited was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family during the period 1986. The Company engaged in manufacturing a...
Read More

Reports by Jenburkt Pharmaceuticals Ltd

Company FAQs

The Jenburkt Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1003.9 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jenburkt Pharmaceuticals Ltd is ₹443.05 Cr. as of 11 Sep ‘26
The PE and PB ratios of Jenburkt Pharmaceuticals Ltd is 12.43 and 2.25 as of 11 Sep ‘26
The 52-week high/low is the highest and lowest price at which a Jenburkt Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Jenburkt Pharmaceuticals Ltd is ₹998.6 and ₹1073.9 as of 11 Sep ‘26
Jenburkt Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at N/I% and 1 Month at -3.94%.
The shareholding pattern of Jenburkt Pharmaceuticals Ltd is as follows:
Promoters - 46.62 %
Institutions - 0.12 %
Public - 53.26 %

QUICKLINKS FOR Jenburkt Pharmaceuticals Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.